Nasdaq:US$31.26 (-1.64) | HKEX:HK$54.80 (-0.35) | AIM:£5.08 (+0.01)
Search
Announcements
12345678910
11
12
found Documents: 584
Announcements & Press Releases, Regulatory Notice | 12 Mar 2010

TR-1: Notification of major interests in shares
a100312
Announcements & Press Releases, Regulatory Notice | 10 Mar 2010

TR-1: Notification of major interests in shares
a100310
Announcements & Press Releases, Regulatory Notice | 8 Mar 2010

TR-1: Notification of Major Interests in Shares
a100308
Announcements & Press Releases, Group | 4 Mar 2010

Final Results for the year ended 31 December 2009
a100304
Announcements & Press Releases, Regulatory Notice | 8 Feb 2010

Notice of Announcement of 2009 Final Results
a100208
Announcements & Press Releases, Regulatory Notice | 2 Feb 2010

Total Voting Rights
a100202
Announcements & Press Releases, Other Ventures | 19 Jan 2010

Three more of Chi-Med's China Healthcare Division drugs added to latest China's National Medicines Catalogue
a100119
Announcements & Press Releases, Regulatory Notice | 4 Jan 2010

Total Voting Rights
a100104
Announcements & Press Releases, Regulatory Notice | 29 Dec 2009

Blocklisting Six Monthly Return
a091229
Announcements & Press Releases, Regulatory Notice | 26 Nov 2009

TR-1 : Notification of Major Interests in Shares
a091126
Announcements & Press Releases, Oncology / Immunology | 5 Nov 2009

Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans
a091105
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2009

Hutchison MediPharma Limited Initiates Phase I Clinical Trial of HMPL-011, Its Novel Single Chemical Drug Candidate for the Treatment of Auto-immune Diseases
a091030
Announcements & Press Releases, Other Ventures | 26 Oct 2009

Chi-Med increases ownership of its Hutchison Healthcare joint venture to 100%
a091026
Announcements & Press Releases, Other Ventures | 16 Oct 2009

Newly Published China National Essential Medicines List Reference Prices No Overall Negative Impact on Chi-Med Prices
a091016
Announcements & Press Releases, Other Ventures | 8 Oct 2009

Chi-Med announces joint venture with The Hain Celestial Group to develop natural and organic consumer products in Asia
a091008
Announcements & Press Releases, Other Ventures | 27 Aug 2009

Chi-Med's Main Drugs Included in the New National Essential Medicines List
a090827
Announcements & Press Releases, Group | 30 Jul 2009

Interim Results for the Six Months Ended 30 June 2009
a090730
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004
a090729
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn's Disease Trial for HMPL-004 Delivers Encouraging Results
a090713
Announcements & Press Releases, Regulatory Notice | 8 Jul 2009

Notice of Announcement of 2009 Interim Results
a090708
Announcements & Press Releases, Regulatory Notice | 30 Jun 2009

Blocklisting Six Monthly Return
a090630
Announcements & Press Releases, Regulatory Notice | 8 May 2009

Results of Annual General Meeting
a090508
Announcements & Press Releases, Regulatory Notice | 9 Apr 2009

Director's Shareholding
a090409
Announcements & Press Releases, Regulatory Notice | 6 Apr 2009

2008 Annual Report and Notice of Annual General Meeting
a090406
Announcements & Press Releases, Regulatory Notice | 20 Mar 2009

TR-1: Notification of major interests in shares
a090320
Announcements & Press Releases, Regulatory Notice | 20 Mar 2009

Date of Annual General Meeting
a090320b
Announcements & Press Releases, Regulatory Notice | 20 Mar 2009

TR-1: Notification of major interests in shares
a090320a
Announcements & Press Releases, Group | 16 Mar 2009

Final Results for the year ended 31 December 2008
a090316
Announcements & Press Releases, Regulatory Notice | 2 Mar 2009

TR-1: Notification of major interests in shares
a090302
Announcements & Press Releases, Regulatory Notice | 27 Feb 2009

Notice of Announcement of 2008 Final Results
a090227
Announcements & Press Releases, Oncology / Immunology | 17 Feb 2009

Chi-Med Announces Completion of Patient Enrolment in its US Phase II Crohn's Disease Clinical Trial of HMPL-004, its Lead Anti-Inflammatory Drug Candidate
a090217
Announcements & Press Releases, Regulatory Notice | 22 Jan 2009

TR-1: Notification of major interests in shares
a090122a
Announcements & Press Releases, Regulatory Notice | 22 Jan 2009

TR-1: Notification of major interests in shares
a090122
Announcements & Press Releases, Regulatory Notice | 21 Jan 2009

Holding in Company
a090121
Announcements & Press Releases, Regulatory Notice | 19 Jan 2009

Director's Shareholding
a090119
Announcements & Press Releases, Oncology / Immunology | 8 Jan 2009

HMPL-002 Clinical Update
a090108
Announcements & Press Releases, Regulatory Notice | 30 Dec 2008

Blocklisting Six Monthly Return
a081230
Announcements & Press Releases, Oncology / Immunology | 23 Dec 2008

Hutchison MediPharma Limited Enters into Drug Discovery and Development Partnership With Ortho-McNeil-Janssen Pharmaceuticals, Inc.
a081223
Announcements & Press Releases, Regulatory Notice | 15 Dec 2008

Director's Shareholding
a081215
Announcements & Press Releases, Oncology / Immunology | 21 Nov 2008

Chi-Med Expands Drug Discovery and Development Partnership With Lilly
a081121
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2008

Hutchison MediPharma wins the 2008 American College of Gastroenterology International Award
a081030
Announcements & Press Releases, Regulatory Notice | 8 Oct 2008

Board Change
a081008
Announcements & Press Releases, Group | 6 Aug 2008

Interim Results for the Six Months Ended 30 June 2008
a080806a
Announcements & Press Releases, Regulatory Notice | 6 Aug 2008

Drug R&D Division: New employee share option scheme in Hutchison MediPharma
a080806
Announcements & Press Releases, Regulatory Notice | 18 Jul 2008

Notice of 2008 Interim Results
a080718
Announcements & Press Releases, Regulatory Notice | 30 Jun 2008

Blocklisting Six Monthly Return
a080630
Announcements & Press Releases, Regulatory Notice | 10 Jun 2008

Director's Shareholding
a080610
Announcements & Press Releases, Regulatory Notice | 2 Jun 2008

Board Change
a080602
Announcements & Press Releases, Other Ventures | 23 May 2008

China Healthcare Division Chi-Med increases ownership of its Hutchison Healthcare joint venture
a080523
Announcements & Press Releases, Other Ventures | 19 May 2008

Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
a080519
12345678910
11
12